{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:51:17Z","timestamp":1761900677885,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R309-A17906"],"award-info":[{"award-number":["R309-A17906"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10552-025-02017-z","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T16:22:51Z","timestamp":1748881371000},"page":"1217-1225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility treatment and risk of non-Hodgkin lymphoma \u2013 results from a Danish population-based cohort study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4976-0794","authenticated-orcid":false,"given":"Anna Kj\u00e6r","family":"Kristensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0956-9765","authenticated-orcid":false,"given":"Clarissa Lima Brown","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9783-4460","authenticated-orcid":false,"given":"Maria","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9744-4452","authenticated-orcid":false,"given":"Bugge","family":"N\u00f8hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-6798","authenticated-orcid":false,"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5370-2589","authenticated-orcid":false,"given":"Jakob Hansen","family":"Viuff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-9242","authenticated-orcid":false,"given":"Marie","family":"Hargreave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8347-1398","authenticated-orcid":false,"given":"Susanne Kr\u00fcger","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8124-4880","authenticated-orcid":false,"given":"Allan","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"2017_CR1","unstructured":"European Society of Human Reproduction and Embryology, ART Fact Sheet 2022, Available from: https:\/\/www.eshre.eu\/Press-Room\/Resources\/Fact-sheets?_gl=1*1o59arf*_up*MQ..*_ga*MTE5MzU3NjU1Mi4xNzI3ODYxNTIy*_ga_JQVYYLVHJP*MTcyNzg2MTUyMi4xLjEuMTcyNzg2MTU0MS4wLjAuMA.. (Accessed from September 3, 2024)."},{"key":"2017_CR2","doi-asserted-by":"publisher","first-page":"10952","DOI":"10.18632\/aging.102497","volume":"11","author":"H Sun","year":"2019","unstructured":"Sun H, Gong TT, Jiang YT, Zhang S, Zhao YH, Wu QJ (2019) Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990\u20132017: results from a global burden of disease study, 2017. Aging 11:10952\u201310991. https:\/\/doi.org\/10.18632\/aging.102497","journal-title":"Aging"},{"key":"2017_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1196\/annals.1365.022","volume":"1092","author":"N Kanakas","year":"2006","unstructured":"Kanakas N, Mantzavinos T (2006) Fertility drugs and gynecologic cancer. Ann N Y Acad Sci 1092:265\u2013278. https:\/\/doi.org\/10.1196\/annals.1365.022","journal-title":"Ann N Y Acad Sci"},{"key":"2017_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fendo.2019.00313","volume":"10","author":"Z Momenimovahed","year":"2019","unstructured":"Momenimovahed Z, Taheri S, Tiznobaik A, Salehiniya H (2019) Do the fertility Drugs increase the risk of cancer? Rev Study Front Endocrinol (Lausanne) 10:313. https:\/\/doi.org\/10.3389\/fendo.2019.00313","journal-title":"Rev Study Front Endocrinol (Lausanne)"},{"key":"2017_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008215.pub3","author":"I Rizzuto","year":"2019","unstructured":"Rizzuto I, Behrens RF, Smith LA (2019) Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008215.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2017_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010931.pub2","author":"A Skalkidou","year":"2017","unstructured":"Skalkidou A, Sergentanis TN, Gialamas SP, Georgakis MK, Psaltopoulou T, Trivella M, Siristatidis CS, Evangelou E, Petridou E (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD010931.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2017_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10549-015-3328-0","volume":"150","author":"A Gennari","year":"2015","unstructured":"Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, Provinciali N, Bruzzi P (2015) Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Res Treat 150:405\u2013413. https:\/\/doi.org\/10.1007\/s10549-015-3328-0","journal-title":"Breast Cancer Res Treat"},{"key":"2017_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/jnci\/djaa163","volume":"113","author":"M Spaan","year":"2021","unstructured":"Spaan M, van den Belt-Dusebout AW, Lambalk CB, van Boven HH, Schats R, Kortman M, Broekmans FJM, Laven JSE, van Santbrink EJP et al (2021) Long-term risk of ovarian cancer and borderline tumors after assisted reproductive technology. J Natl Cancer Inst 113:699\u2013709. https:\/\/doi.org\/10.1093\/jnci\/djaa163","journal-title":"J Natl Cancer Inst"},{"key":"2017_CR9","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","volume":"36","author":"JF Barcroft","year":"2021","unstructured":"Barcroft JF, Galazis N, Jones BP, Getreu N, Bracewell-Milnes T, Grewal KJ, Sorbi F, Yazbek J, Lathouras K et al (2021) Fertility treatment and cancers-the eternal conundrum: a systematic review and meta-analysis. Hum Reprod 36:1093\u20131107. https:\/\/doi.org\/10.1093\/humrep\/deaa293","journal-title":"Hum Reprod"},{"key":"2017_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13048-022-01084-z","volume":"16","author":"L Yu","year":"2023","unstructured":"Yu L, Sun J, Wang Q, Yu W, Wang A, Zhu S, Xu W, Wang X (2023) Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis. J Ovarian Res 16:22. https:\/\/doi.org\/10.1186\/s13048-022-01084-z","journal-title":"J Ovarian Res"},{"key":"2017_CR11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.fertnstert.2015.06.045","volume":"104","author":"LA Brinton","year":"2015","unstructured":"Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015) Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril 104:980\u2013988. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.06.045","journal-title":"Fertil Steril"},{"key":"2017_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/GCO.0000000000000370","volume":"29","author":"L Kroener","year":"2017","unstructured":"Kroener L, Dumesic D, Al-Safi Z (2017) Use of fertility medications and cancer risk: a review and update. Curr Opin Obstet Gynecol 29:195\u2013201. https:\/\/doi.org\/10.1097\/GCO.0000000000000370","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2017_CR13","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.jid.2021.02.752","volume":"141","author":"L Freund","year":"2021","unstructured":"Freund L, Kj\u00e6r SK, Guleria S, Albieri V, Nybo Andersen AM, Frederiksen K, Jensen A (2021) Use of fertility drugs and risk of malignant melanoma: results from a large danish population-based cohort study. J Invest Dermatol 141:2189\u20132196. https:\/\/doi.org\/10.1016\/j.jid.2021.02.752","journal-title":"J Invest Dermatol"},{"key":"2017_CR14","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/humrep\/deab285","volume":"37","author":"S Lindquist","year":"2022","unstructured":"Lindquist S, Kj\u00e6r SK, Albieri V, Frederiksen K, Hansen T, N\u00f8hr B, Jensen A (2022) Fertility drugs and incidence of thyroid cancer in a Danish nationwide cohort of 146 024 infertile women. Hum Reprod 37:838\u2013847. https:\/\/doi.org\/10.1093\/humrep\/deab285","journal-title":"Hum Reprod"},{"key":"2017_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.fertnstert.2022.06.029","volume":"118","author":"M M\u00f8ller","year":"2022","unstructured":"M\u00f8ller M, Kj\u00e6r SK, Lindquist S, Brown Frandsen CL, Albieri V, Viuff JH, N\u00f8hr B, Olsen A, Jensen A (2022) Risk of colorectal cancer after use of fertility drugs-results from a large Danish population-based cohort of women with infertility. Fertil Steril 118:738\u2013747. https:\/\/doi.org\/10.1016\/j.fertnstert.2022.06.029","journal-title":"Fertil Steril"},{"key":"2017_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/medsci9010005","volume":"9","author":"KC Thandra","year":"2021","unstructured":"Thandra KC, Barsouk A, Saginala K, Padala SA, Barsouk A, Rawla P (2021) Epidemiology of non-Hodgkin\u2019s lymphoma. Med Sci (Basel) 9:5. https:\/\/doi.org\/10.3390\/medsci9010005","journal-title":"Med Sci (Basel)"},{"key":"2017_CR17","doi-asserted-by":"publisher","first-page":"1059914","DOI":"10.3389\/fonc.2023.1059914","volume":"13","author":"Y Chu","year":"2023","unstructured":"Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge X, Yuan D, Lu K, Li P et al (2023) The epidemiological patterns of non-Hodgkin lymphoma: global estimates of disease burden, risk factors, and temporal trends. Front Oncol 13:1059914. https:\/\/doi.org\/10.3389\/fonc.2023.1059914","journal-title":"Front Oncol"},{"key":"2017_CR18","unstructured":"Bray F, Colombet M, Aitken JF, Bardot A, Eser S, Galceran J, Hagenimana M, Matsuda T, Mery L, et al.(2023). Cancer Incidence in Five Continents, Vol. XII (IARC CancerBase No. 19). Lyon: International Agency for Research on Cancer."},{"key":"2017_CR19","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2009.1.523","author":"ES Jaffe","year":"2009","unstructured":"Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematol Am Soc Hematol Educ Prog. https:\/\/doi.org\/10.1182\/asheducation-2009.1.523","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"2017_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/00313020500370192","volume":"37","author":"AE Grulich","year":"2005","unstructured":"Grulich AE, Vajdic CM (2005) The epidemiology of non-Hodgkin lymphoma. Pathology 37:409\u2013419. https:\/\/doi.org\/10.1080\/00313020500370192","journal-title":"Pathology"},{"key":"2017_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/10428194.2016.1213828","volume":"58","author":"EE Ladikou","year":"2017","unstructured":"Ladikou EE, Kassi E (2017) The emerging role of estrogen in B cell malignancies. Leuk Lymphoma 58:528\u2013539. https:\/\/doi.org\/10.1080\/10428194.2016.1213828","journal-title":"Leuk Lymphoma"},{"key":"2017_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/10245332.2017.1389508","volume":"23","author":"S Faknuam","year":"2018","unstructured":"Faknuam S, Assanasen T, Ruangvejvorachai P, Hanvivadhanakul P, Intragumtornchai T, Rojnuckarin P (2018) Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma. Hematology 23:235\u2013241. https:\/\/doi.org\/10.1080\/10245332.2017.1389508","journal-title":"Hematology"},{"key":"2017_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1200\/JCO.2001.19.5.1381","volume":"19","author":"RA Nelson","year":"2001","unstructured":"Nelson RA, Levine AM, Bernstein L (2001) Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin\u2019s lymphoma in women. J Clin Oncol 19:1381\u20131387. https:\/\/doi.org\/10.1200\/JCO.2001.19.5.1381","journal-title":"J Clin Oncol"},{"key":"2017_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008135","volume":"4","author":"J Prescott","year":"2009","unstructured":"Prescott J, Lu Y, Chang ET, Sullivan-Halley J, Henderson KD, Clarke CA, Ma H, Templeman C, Deapen D et al (2009) Reproductive factors and non-Hodgkin lymphoma risk in the California teachers study. PLoS ONE 4:e8135. https:\/\/doi.org\/10.1371\/journal.pone.0008135","journal-title":"PLoS ONE"},{"key":"2017_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/aje\/kwh278","volume":"160","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang B, Zou K, Morton LM, Owens PH et al (2004) Menstrual and reproductive factors and risk of non-Hodgkin\u2019s lymphoma among Connecticut women. Am J Epidemiol 160:766\u2013773. https:\/\/doi.org\/10.1093\/aje\/kwh278","journal-title":"Am J Epidemiol"},{"key":"2017_CR26","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/sj.bjc.6603123","volume":"94","author":"M N\u00f8rgaard","year":"2006","unstructured":"N\u00f8rgaard M, Poulsen AH, Pedersen L, Gregersen H, Friis S, Ewertz M, Johnsen HE, S\u00f8rensen HT (2006) Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin\u2019s lymphoma: a Danish population-based cohort study. Br J Cancer 94:1339\u20131341. https:\/\/doi.org\/10.1038\/sj.bjc.6603123","journal-title":"Br J Cancer"},{"key":"2017_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1023\/a:1014354105164","volume":"13","author":"JR Cerhan","year":"2002","unstructured":"Cerhan JR, Habermann TM, Vachon CM, Putnam SD, Zheng W, Potter JD, Folsom AR (2002) Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women\u2019s health study (United States). Cancer Causes Control 13:131\u2013136. https:\/\/doi.org\/10.1023\/a:1014354105164","journal-title":"Cancer Causes Control"},{"key":"2017_CR28","first-page":"1466","volume":"11","author":"JR Cerhan","year":"2002","unstructured":"Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD et al (2002) Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 11:1466\u20131471","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2017_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/aje\/kwy259","volume":"188","author":"L Costas","year":"2019","unstructured":"Costas L, Lujan-Barroso L, Benavente Y, Allen NE, Amiano P, Ardanaz E, Besson C, Boeing H, Bueno-de-Mesquita B et al (2019) Reproductive factors, exogenous hormone use, and risk of b-cell non-Hodgkin lymphoma in a cohort of women from the European prospective investigation into cancer and nutrition. Am J Epidemiol 188:274\u2013281. https:\/\/doi.org\/10.1093\/aje\/kwy259","journal-title":"Am J Epidemiol"},{"key":"2017_CR30","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/sj.bjc.6605086","volume":"100","author":"S Silva Idos","year":"2009","unstructured":"Silva Idos S, Wark PA, McCormack VA, Mayer D, Overton C, Little V, Nieto J, Hardiman P, Davies M et al (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 100:1824\u20131831. https:\/\/doi.org\/10.1038\/sj.bjc.6605086","journal-title":"Br J Cancer"},{"key":"2017_CR31","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/humrep\/des031","volume":"27","author":"AN Yli-Kuha","year":"2012","unstructured":"Yli-Kuha AN, Gissler M, Klemetti R, Luoto R, Hemminki E (2012) Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 27:1149\u20131155. https:\/\/doi.org\/10.1093\/humrep\/des031","journal-title":"Hum Reprod"},{"key":"2017_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R Calderon-Margalit","year":"2016","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O (2016) Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 169:365\u2013375. https:\/\/doi.org\/10.1093\/aje\/kwn318","journal-title":"Am J Epidemiol"},{"key":"2017_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/0284186X.2015.1115124","volume":"55","author":"LF Ocias","year":"2016","unstructured":"Ocias LF, Larsen TS, Vestergaard H, Friis LS, Abildgaard N, Frederiksen H, Academy of Geriatric Cancer Research (AgeCare) (2016) Trends in hematological cancer in the elderly in Denmark 1980\u20132012. Acta Oncol 55:98\u2013107. https:\/\/doi.org\/10.3109\/0284186X.2015.1115124","journal-title":"Acta Oncol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-02017-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-02017-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:22:34Z","timestamp":1761898954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-02017-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2017"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-02017-z","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.N. received grants from Gedeon Richter Nordics AB, IBSA Nordic APS, and Merck KGAA, consulting fees from Ferring Pharmaceuticals A\/S, honoraria for lectures from Organon Denmark ApS, and support for meeting attendance from Gedeon Richter Nordics AB. The remaining authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Danish Health Data Board and Statistics Denmark (J.nr. 704645) and the Local Ethical Committees for Copenhagen and Frederiksberg municipalities (J.nr. 01\u2013298\/96) and approved and registered in the archive list DCS-DCRC-2100 of the Danish Cancer Institute (J.nr. 2019-DCRC-0020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}